Contrarily, our data indicate that PTH1R expression is higher in the least malignant, MYCN nonamplified neuroblastic tumors, and its knockdown promoted increased cell invasion and migration in neuroblastoma cell lines. The gene discussed is MYCN; the disease is neuroblastoma.